This company listing is no longer active
Reevo Crecimiento futuro
Future controles de criterios 4/6
Reevo is forecasted to grow earnings and revenue by 27.4% and 15.1% per annum respectively. EPS is expected to grow by 27.2%. Return on equity is forecast to be 17.5% in 3 years.
Información clave
27.4%
Tasa de crecimiento de los beneficios
27.2%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de IT | 13.9% |
Tasa de crecimiento de los ingresos | 15.1% |
Rentabilidad financiera futura | 17.5% |
Cobertura de analistas | Low |
Última actualización | 18 Apr 2023 |
Actualizaciones recientes sobre el crecimiento futuro
Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2025 | 30 | 4 | 4 | 7 | 2 |
12/31/2024 | 26 | 3 | 3 | 6 | 2 |
12/31/2023 | 21 | 2 | 1 | 4 | 2 |
12/31/2022 | 15 | 1 | -1 | 4 | N/A |
9/30/2022 | 14 | 2 | 0 | 3 | N/A |
6/30/2022 | 14 | 2 | 0 | 3 | N/A |
3/31/2022 | 12 | 2 | 0 | 3 | N/A |
12/31/2021 | 11 | 1 | 1 | 3 | N/A |
9/30/2021 | 11 | 1 | 0 | 2 | N/A |
6/30/2021 | 10 | 1 | 0 | 2 | N/A |
3/31/2021 | 9 | 1 | 0 | 1 | N/A |
12/31/2020 | 8 | 1 | 0 | 1 | N/A |
12/31/2019 | 5 | 0 | 0 | 1 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: REEVO's forecast earnings growth (27.4% per year) is above the savings rate (2.1%).
Beneficios vs. Mercado: REEVO's earnings (27.4% per year) are forecast to grow faster than the Italian market (8% per year).
Beneficios de alto crecimiento: REEVO's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: REEVO's revenue (15.1% per year) is forecast to grow faster than the Italian market (-0.1% per year).
Ingresos de alto crecimiento: REEVO's revenue (15.1% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: REEVO's Return on Equity is forecast to be low in 3 years time (17.5%).